Intellia Therapeutics, Inc NTLA
$12.14
-0.98%
at last close
Financials (TTM)
- Revenue
- $59.51 million
- Net Income
- $-399,975,000
- Net Margin
- -672.16%
- Return on Equity
- -54.96%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.36
- Price / Sales
- 28.87
Over the trailing twelve months, Intellia Therapeutics, Inc generated revenue of $59.51 million and net income of $-399,975,000, a net margin of -672.16%.
At the last closing price of $12.14, NTLA trades at 28.87 times sales, with a market capitalization of $1.72 billion.
Key Stats
- Last Close
- $12.14
- Market Cap
- $1.72 billion
- 52-Week Range
- $7.95 – $28.25
- Average Volume
- 3.61 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.